CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Report for D001289: Attention Deficit Disorder with Hyperactivity NIH

(Synonyms: Attention D, Attention De, Attention Def, Attention Deficit , Attention Deficit D, Attention Deficit Di, Attention Deficit Diso, Attention Deficit Disorder , Attention Deficit Disorder w, Attention Deficit Disorder wit, Attention Deficit Disorder with H, Attention Deficit Disorder with Hyp, Attention Deficit Disorder with Hypera, Attention Deficit Disorder with Hyperactivity)

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug287 Caption AI Wiki 1.00
drug702 Interview by psychologists Wiki 1.00

Correlated MeSH Terms (5)


Name (Synonyms) Correlation
D000067877 Autism Spectrum Disorder NIH 1.00
D006948 Hyperkinesis NIH 1.00
D002659 Child Development Disorders, Pervasive NIH 1.00
D001321 Autistic Disorder NIH 1.00
D004194 Disease NIH 0.38

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Clinical Evolution and Parenting in Children and Adolescents With Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder Quarantined Because of Covid-19 Outbreak

In response to the coronavirus disease 2019 (covid-19) outbreak, the home confinement of the population ordered by governments in many countries raise questions about its impact on individuals' physical and mental health in the short and longer term. In children, reduced physical activity, changes in lifestyle, disturbances in sleep patterns, lack of in-person contact with peers, poor or inadequate understanding of health risks may be risk factors of anxiety, stress, fatigue, sleep disorders (Brooks et al, 2020; Wang et al, 2020; Sprang et al, 2013). These problematic effects could be modulated by social factors (housing in urban or rural areas, availability of personal space at home, parenting stress, etc.) (Cluver et al, 2020; Liu et al, 2020).

NCT04416360 Autism Spectrum Disorder Attention-deficit Hyperactivity Disorder Other: Interview by psychologists
MeSH:Hyperkinesis Disease Autistic Disorder Attention Deficit Disorder with Hyperactivity Autism Spectrum Disorder Child Development Disorders, Pervasive
HPO:Attention deficit hyperactivity disorder Autism Autistic behavior Hyperactivity Hyperkinetic movements

Primary Outcomes

Description: composition, home confinement, change in the environment, personal room at home, screens with internet access, parents' current professional status, teleworking, care, family concerns related to Covid-19, parenting stress, schooling, recurrent complaints.

Measure: Interview of the parents : contextual data

Time: Baseline

Description: related to education; related to daily family life; related to leisure, related to care (children/adolescents, parents)

Measure: Interview of the children/adolescents/ parents : Experience of the confinement in general

Time: Baseline

Description: related to education; related to daily family life; related to leisure, related to care (children/adolescents, parents)

Measure: Interview of the children/adolescents/ parents : Experience of the confinement in general

Time: 1 month

Description: related to education; related to daily family life; related to leisure, related to care (children/adolescents, parents)

Measure: Interview of the children/adolescents/ parents : Experience of the confinement in general

Time: 3 months

Description: Data relating to disease and management of care. Experience of the referring caregiver.

Measure: Interview of the referring caregiver : data relating to disease and management of care

Time: 3 months


HPO Nodes


HP:0007018: Attention deficit hyperactivity disorder
Genes 280
TRNF MID2 MKRN3-AS1 ACTL6B PTCHD1 SYNJ1 UBE3A TRAK1 CXORF56 SMPD1 USP7 CLTC FLI1 SMC3 FGF12 BCR KCNB1 TBX1 ARHGEF6 TRIO PAH DHTKD1 SLITRK1 KIF14 YWHAG SIN3A CHD7 PWRN1 TRNL1 SETD5 PPM1D LIMK1 OCRL TBL2 CRBN KIF11 ARF1 HCFC1 SLC1A2 KCNA2 USP9X STS CNKSR2 ALKBH8 SH3KBP1 RPS20 DPH1 TAF1 DYNC1I2 YY1 HDAC8 CIC SLC9A7 IKBKG TSPAN7 TBX1 NR2F1 ALG13 HERC2 ND1 TKT KMT2A SLC6A8 TMCO1 PRKCG COX2 HIRA GNE RAI1 GABRA1 LIG4 SH2B1 SIM1 SEMA4A MED12 RAD21 GABRB2 GDI1 TBC1D24 UFD1 GRIA4 PHIP CLIP2 IL1RAPL1 SATB2 SETD5 NBN NIPBL CACNA1A GNE CSNK2A1 PCGF2 SH2B1 TRNQ PRNP NDP SIN3A CNKSR2 JMJD1C SRPX2 DNM1 CPLX1 IFNG AUTS2 ARID2 HSPG2 GRIN2A THRB SNORD116-1 MLH1 IPW GABRA5 STAG2 GABRB3 BMPR1A ZDHHC9 DHCR7 HDC ACSL4 GLUD1 TRNS1 FGD1 PMS1 CLCN4 TSC1 KCNA2 SOX5 HOXA2 MAP11 SEC24C SLC2A1 ADNP SMC1A MSH6 EEF1A2 FLII NOP56 MKRN3 PIK3CA ATP6V1A CACNA1H PAH HCN1 CACNA1B DLG3 GRIN2D GABRG2 IQSEC2 EPCAM CHRNA7 UPF3B NDN PAK3 ABCD1 IQSEC2 KRAS MCTP2 C12ORF4 SNORD115-1 TSC2 TLK2 PMS2 TSC2 PPP3CA SYP BCORL1 COMT SZT2 PCNT ARVCF GTF2I VPS13A FTSJ1 TRNW COX3 TGFBR2 ASPM GNB5 SPG7 ZNF41 UPF3B RERE SYNGAP1 STS GATA4 DRD5 OPHN1 TRNH COX1 GNAQ ELN AGTR2 TBX1 LHCGR FGFR3 YWHAG TBX1 ND5 DNAJC12 AP3B2 FGD1 ND4 DHDDS PTCHD1 TRNS2 UBA5 CNKSR2 MLXIPL USP27X HDAC4 RAI1 MAGEL2 DMD ELN SNRPN NUS1 RSRC1 WAC TRIO PWAR1 ARV1 RREB1 TIMM8A ARX NPAP1 GABRG2 BAZ1B TUBB2B FAN1 SPRED1 WWOX POLA1 DEAF1 SCN8A SETBP1 SLC13A5 STXBP1 DPP6 GABRG2 RAI1 DRD4 SCN8A DYM ZNF711 PARS2 GP1BB JRK TKT CYFIP2 AARS1 MSH2 RFC2 PIEZO2 MAPK1 NTRK2 MED12 NSUN2 FRMPD4 MED12 GRIN2A PANK2 RAB39B MLH3 FOXP1 ND6 SCN3A RPS6KA3 CRKL FMR1 IGF1 MECP2 SEMA3E RERE NECAP1 GTF2IRD1 ZNF81 MED12 CLTC TSC1 GABRA2
Protein Mutations 2
D203E G143E